TD Cowen Raises Tandem Diabetes (TNDM) Price Target, Keeps Buy Rating

Summary

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) is one of the 10 Best Medical Stocks to Buy Under $30. On April 20, TD Cowen lifted its price target on Tandem Diabetes...

Original reporting

AFBytes is a read-only aggregator. Use the original source for full context and complete reporting.

Related coverage